David Nicholas DeVaro

Mr. David Nicholas DeVaro

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
OBOmar Bushara
Omar Bushara
DDDavid Nicholas DeVaro
David Nicholas DeVaro
SAShawn S. Ahn
Shawn S. Ahn
JDJordan Dourlain
Jordan Dourlain
MFMohammad S. Farooq
Mohammad S. Farooq
SSSunil Singhal
Sunil Singhal
Introduction: SETD2 is an understudied gene that encodes for a histone methyltransferase implicated in lung cancer tumorigenesis and is found in up to 10% of all non-small cell lung cancer. With the largest cohort to date, we aim to elucidate the clinicopathologic characteristics and prognosis of SETD2-mutated lung adenocarcinoma. Methods: We obtained molecular genetics reports of lung cancer seen between 1 January 2015 and 4 January 2024. We identified all SETD2-mutated cancer and identified 500 consecutive cases prior to 4 January 2020 as a control group. Non-recurrent adenocarcinomas were included. Patient and tumor characteristics and recurrence-free survival (RFS) were compared. Fisher’s exact, Wilcoxon rank sum, and log-rank tests were used when appropriate. Kaplan–Meier plots and Cox proportional hazards models were used to analyze recurrence-free survival. Results: A total of 67 SETD2-mutated lung and 174 non-SETD2-mutated lung adenocarcinomas met inclusion criteria. SETD2-mutated tumors presented at earlier stages (55.2% vs. 17.8% stage I, 11.9% vs. 48.3% stage IV, p < 0.001). SETD2-mutated adenocarcinoma had a higher number of genetic mutations (median: 11 IQR: [8–15] vs. 7 [5–10], p < 0.001). In a univariable Cox analysis, SETD2 mutation was associated with improved RFS (HR 0.53 95% CI: [0.33–0.85], p = 0.008). In a covariate-adjusted model, SETD2 mutation trended towards improved RFS (0.71 [0.43–1.18], p = 0.10). Conclusions: These data suggest SETD2-mutated lung adenocarcinoma presents at significantly earlier stages, has a unique molecular profile compared to non-mutated tumors, and trends towards improved RFS in early-stage tumors. Future study is warranted on both patient outcomes and immunopathologic characteristics of SETD2-mutated lung adenocarcinoma.

11 September 2025 in Vascular
Verified
Journal Article
Open access
DDDavid Nicholas DeVaro
David Nicholas DeVaro
AFAlexander S Fairman
Alexander S Fairman
Objectives: Pediatric arterial aneurysms are very uncommon. Those without an underlying identifiable etiology such as infection or autoimmune disease are even rarer. In young children, options for repair are limited. We report the case of a pediatric common iliac artery aneurysm that was surgically repaired. Methods: A 27-month-old male presenting for an evaluation of persistent hypertension underwent an abdominal CT scan and was incidentally found to have a large right common iliac artery aneurysm along with a thrombosed, proximal right internal iliac artery aneurysm. Given the size, the aneurysm was repaired with a bypass constructed from cryopreserved femoral artery allograft. Results: The procedure was uncomplicated, with continued patency of the graft determined via ultrasound at 7 months. Conclusion: A pediatric iliac artery aneurysm was successfully repaired with a cadaveric femoral artery graft in the setting of limited conduit options.

25 July 2025 in Pathobiology
Verified
Journal Article
Closed access
OBOmar Bushara
Omar Bushara
CDCharles Crepy D'Orleans
Charles Crepy D'Orleans
YKYash Kadakia
Yash Kadakia
RARucha Alur
Rucha Alur
DDDavid Nicholas DeVaro
David Nicholas DeVaro
SSSunil Singhal
Sunil Singhal
Background: Lung cancer is the leading cause of cancer related death in the USA. A proven risk factor for the development and progression of lung cancer is human immunodeficiency virus (HIV). Summary: HIV persists within the lung in alveolar macrophages and bronchial epithelial cells, reducing mucociliary function and decreasing epithelial integrity. This persistence yields chronic inflammation by way of matrix metalloproteinases, which causes pulmonary injury. Over time, this progresses to pulmonary disease and allows for the development of superimposed pulmonary infections and chronic inflammatory states. This injury is a risk factor for the development of dysplasia, and chronic pulmonary disease and infections further increase the risk for developing lung cancer. HIV persistence and chronic inflammation also lead to CD8+ T cell exhaustion and alterations to macrophages and dendritic cells that blunt the physiologic antitumor response. As such, HIV infection promotes initial dysplasia and allows for progression on preinvasive lesions to frank malignancy. Key Messages: The purpose of this review is to highlight HIV as an under-appreciated risk factor and summarize the biologic and immunologic role of HIV in lung cancer initiation and progression. Further research regarding risk reduction and surveillance in this population and the potential increased role of immunotherapy is warranted.

21 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
DDDavid Nicholas DeVaro
David Nicholas DeVaro
SRSridharan Raghavan
Sridharan Raghavan
VWVenexia Walker
Venexia Walker
TGTom Gaunt
Tom Gaunt
Susanna C. LarssonSusanna C. Larsson
Susanna C. Larsson
SDScott M. Damrauer
Scott M. Damrauer
Background: Type 2 diabetes (T2D) has been associated with reduced abdominal aortic aneurysm (AAA) risk and slower growth in observational studies, but the mechanism for this paradoxical association remains unclear. We hypothesized that T2D’s mechanistic heterogeneity obscures opposing, pathway-specific effects on AAA. Methods: We performed two-sample Mendelian Randomization (MR) to investigate the effect of T2D (T2DGGI, 242,283 individuals with T2D and 1,569,730 without) on AAA (AAAgen, 37,214 individuals with AAA and 997,456 without) using 449 genetic instruments. We also performed MR within previously defined clusters representing different mechanisms of T2D. We extended the analysis to individual hyperglycemic, insulin-resistance, and insulin-sensitivity traits. Our hypothesis was tested in a porcine pancreatic elastase murine model of abdominal aortic aneurysm formation. Results: Overall T2D liability showed no net association with AAA liability (OR 1.00, 95% CI 0.96-1.04, P = 0.90), albeit with marked instrument heterogeneity (Cochran’s Q = 1356, P = 5 x 10 -92 ) and inconsistency across sensitivity analyses, with a notably protective MR-Egger result (OR 0.87, 95% CI 0.80-0.94, P = 0.0011) and non-zero intercept ( P = 2 x 10 -4 ). MR of T2D on AAA within mechanistic clusters showed opposing effects: lipodystrophy (OR 1.47, 95% CI 1.26-1.72) and obesity (OR 1.27, 95% CI 1.18-1.36) cluster membership associated with increased AAA risk, while beta-cell negative proinsulin (OR 0.83, 95% CI 0.76-0.90) and beta-cell positive proinsulin (OR 0.86, 95% CI 0.80-0.93) clusters were protective. This pattern was robust to clustering method. Traits indexing hyperglycemia (fasting glucose, 2-hour glucose, hemoglobin A1c) were associated with reduced AAA risk, while traits indexing insulin resistance (fasting insulin, BMI, waist-hip ratio, triglyceride-to-HDL ratio) were associated with increased AAA risk. In mice, those treated with a high fructose diet as a model for insulin resistance showed increased growth of the abdominal aorta compared with controls, whereas those treated with pancreatoxin streptozotocin as a model for isolated hyperglycemia showed blunted growth. Conclusion: Distinct components of T2D physiology may have differential effects on AAA development. Whereas insulin resistance may promote AAA, hyperglycemia appears to protect against it. Our findings support insulin sensitization as a rational direction for AAA pharmacotherapy and suggest that the pathways mediating the protective effect of hyperglycemia may harbor additional therapeutic targets.